AXA/2025/FY/Earnings presentation: Difference between revisions
Content deleted Content added
PlumBot: publish from draft |
PlumBot: publish from draft |
||
Line 19:
=== Full Year 2025 earnings presentation ===
* AXA '''
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures ===
* '''Forward-looking statements''' include predictions of or indicate future events, trends, plans, expectations, or objectives <sup>p. 2</sup>.
** Statements regarding expected '''
**
* '''
** APMs include "underlying earnings", UEPS ("underlying earnings per share"), "underlying return on equity", "combined ratio", and "debt gearing" <sup>p. 2</sup>.
** Reconciliations of APMs to the most closely related IFRS line items are provided in AXA's Activity Report as of December 31, 2025 <sup>p. 2</sup>.
* '''Financial statements''' for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by AXA's statutory auditors <sup>p. 2</sup>.
=== Table of contents ===
* '''FY25 Highlights''' presented by Thomas Buberl, Group CEO <sup>p.
* '''FY25 Business Performance''' presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p.
* '''FY25 Financial Performance''' presented by Alban de Mailly Nesle, Group CFO <sup>p.
== FY25 Highlights ==
* '''
=== Full Year 2025 | Excellent performance ===
Line 46 ⟶ 47:
|+ Key financial highlights, FY25 <sup>p. 5</sup>
! style="text-align:left" | Metric
! class="col-
|-
| style="text-align:left" | Revenues
| class="col-
|-
| style="text-align:left" | Underlying EPS
| class="col-
|-
| style="text-align:left" | Return on equity
| class="col-
|-
| style="text-align:left" | Solvency II ratio
| class="col-
|-
| style="text-align:left" |
| class="col-
|}
</div>
* Dividend proposed by AXA's Board of Directors on February 25, 2026, subject to approval by the Shareholders' Annual General Meeting on April 30, 2026
* Share buyback approved by AXA's Board of Directors on February 25, 2026, expected to commence as soon as reasonably practicable
* Future outlook indicates confidence to deliver underlying EPS growth at the upper end of the 6%-8% target range for 2026
=== Executing the plan on growth, margin and efficiency ===
Line 74 ⟶ 73:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying earnings
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change (
! class="col-s" style="text-align:right" | Change (excluding AXA IM)
|-
Line 88 ⟶ 87:
|}
</div>
* Top line growth +6% LFL, well balanced across lines: P&C +5%, Life +9%, Health +5%
* Record profitability driven by further margin expansion in P&C and L&H, alongside improvement in efficiency
* Scaling the business through continued investments in growth and technology
* Earnings growth
=== Diversified franchise, well positioned in an attractive industry ===
Line 97 ⟶ 96:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Business mix
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Share
Line 118 ⟶ 117:
</div>
* '''Secular trends'''
* '''Our right to win''' is supported by four strategic pillars:
** Leading brand & high customer NPS
** Strong and diversified distribution
** Technical expertise to price & underwrite risks
** Scale offering cost advantage
=== Laying the foundation for the next plan ===
* '''Strategic pillars''' established to lay the foundation for the next plan <sup>p. 8</sup>:
** '''Clear tech and AI roadmap''' <sup>p. 8</sup>
** '''Driving efficiency''' <sup>p. 8</sup>
** '''Enhancing capital allocation''' discipline <sup>p. 8</sup>
** '''Building resilience''' <sup>p. 8</sup>
* '''Earnings growth'''
== FY25 Business Performance ==
* '''Section 2''': FY25 Business Performance
=== Strong delivery across our businesses ===
Line 146 ⟶ 141:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Key financial metrics by region <sup>p. 10</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | % of total GWP
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | Underlying earnings
! class="col-s" style="text-align:right" | Underlying earnings
|-
| style="text-align:left" | France
Line 182 ⟶ 178:
|}
</div>
* ''Note: Change for Gross written premiums is at constant scope and FX, and for underlying earnings at constant FX. FY25 gross written premiums exclude AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.''
=== P&C | Strong margins, confidence in sustaining growth ===
Line 188 ⟶ 186:
{| class="wikitable fintable"
|+ GWP mix <sup>p. 11</sup>
! style="text-align:left" |
! class="col-s" style="text-align:right" | GWP
|-
Line 198 ⟶ 196:
|-
| style="text-align:left" | AXA XL (Large & Specialty)
| style="text-align:right" |
|}
</div>
* '''Underlying earnings''' +9% LFL to EUR 5.9bn.
* '''GWP mix''': Total GWP EUR 58bn, split across Retail, SME & Mid-market, and AXA XL (Large & Specialty).
* '''Retail and SME & Mid-market strategy'''
** '''2025''': Growing volumes while expanding margins
** '''Beyond 2025''': Investing to improve customer retention
* '''AXA XL (Large & Specialty) strategy'''
** '''2025''': Profitable growth with stable margins
** '''Beyond 2025''': Capitalizing on attractive growth opportunities and continued cycle management
* '''Strategic enablers''':
** Continued progress on efficiency
** Higher investment income
** Data & AI to further enhance customer experience
=== L&H | Good momentum, well positioned to capture growth opportunities ===
Line 222 ⟶ 217:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ GWP mix
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" |
|-
| style="text-align:left
| style="text-align:right
|-
| style="text-align:left" | Underlying earnings
| style="text-align:right" | 3.5
|-
| style="text-align:left" | Underlying earnings LFL change
| style="text-align:right" | +7%
|-
| style="text-align:left" | Long-term business
| style="text-align:right" | —
|-
| style="text-align:left" | Short-term business
| style="text-align:right" | —
|}
</div>
* '''Long-term business''' strategic priorities:
** '''2025''': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>
** '''Beyond 2025''': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>
* '''Short-term business''' strategic
** '''2025''': Growing technical results while absorbing Mexico VAT impact <sup>p. 12</sup>
** '''Beyond 2025''': Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>
Line 248:
** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>
* '''Section
* '''Presenter''': Alban de Mailly Nesle, Group CFO <sup>p. 13</sup>
=== P&C | Continued disciplined growth ===
Line 256 ⟶ 257:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ GWP &
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL
! class="col-s" style="text-align:right" | o/w pricing
! class="col-s" style="text-align:right" | o/w volume
Line 293 ⟶ 294:
|}
</div>
* '''Commercial lines''':
** Continued pricing momentum and volume growth in Mid-market and SME <sup>p. 14</sup>
** Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance <sup>p. 14</sup>
* '''AXA XL Reinsurance''':
** Growth supported by alternative capital <sup>p. 14</sup>
* '''Retail lines''':
** Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25) <sup>p. 14</sup>
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
Line 302 ⟶ 306:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Combined ratio components, FY24 vs FY25 <sup>p. 15</sup>
! style="text-align:left" | %
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Undiscounted CY loss ratio (ex Nat Cat)
Line 330:
| style="text-align:right" | -3.6
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Combined ratio
| style="text-align:right" | 91.0
| style="text-align:right" | 90.6
|}
</div>
* '''Undiscounted CY loss ratio''' (ex Nat Cat) improved from:
**
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management <sup>p. 15</sup>
* '''Expense ratio''' improved reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology <sup>p. 15</sup>
*
*
=== P&C | Earnings growth from higher underwriting and financial result ===
Line 372 ⟶ 376:
|}
</div>
* '''Underlying earnings''' grew +9% at constant FX.
* '''Underwriting result''' improved from strong volume growth and improved all-year combined ratio while enhancing reserve prudence
* '''Investment income''' increased reflecting higher volumes and better reinvestment yields on fixed income assets
* '''
* '''Forex impact''' was unfavorable, notably due to USD depreciation vs. EUR
=== Life & Health | Strong growth in premiums, positive net flows ===
Line 385 ⟶ 386:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
! class="col-s" style="text-align:right" | Net flows
|-
| style="text-align:left" | '''Life GWP & other revenues'''
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
| style="text-align:right" | +9%
| style="text-align:right" | —
|-
| style="text-align:left" | Protection
Line 395 ⟶ 403:
| style="text-align:right" | 17.3
| style="text-align:right" | +11%
| style="text-align:right" | +4.9
|-
| style="text-align:left" | Unit-linked
Line 400 ⟶ 409:
| style="text-align:right" | 9.3
| style="text-align:right" | +13%
| style="text-align:right" | +1.5
|-
| style="text-align:left" | Capital light G/A
Line 405 ⟶ 415:
| style="text-align:right" | 9.0
| style="text-align:right" | +7%
| style="text-align:right" | +1.2
|-
| style="text-align:left" | Traditional G/A
Line 410 ⟶ 421:
| style="text-align:right" | 1.9
| style="text-align:right" | -7%
| style="text-align:right" | -5.0
|-
| style="text-align:left" | Employee
| style="text-align:right" | —
| style="text-align:right" | 12.9
| style="text-align:right" | +4%
| style="text-align:right" | —
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
| style="text-align:right" | —
|-
| style="text-align:left" | Individual
Line 435 ⟶ 439:
| style="text-align:right" | 10.5
| style="text-align:right" | +6%
| style="text-align:right" | —
|-
| style="text-align:left" | Group
Line 440 ⟶ 445:
| style="text-align:right" | 8.5
| style="text-align:right" | +4%
| style="text-align:right" | +2.7
|-
| style="text-align:left" |
| style="text-align:right" | +1.5
| style="text-align:right" | +5.4
| style="text-align:right" | —
| style="text-align:right" | —
|}
</div>
Line 485 ⟶ 459:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ PVEP,
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | LFL Change
|-
| style="text-align:left" | '''PVEP'''
| style="text-align:right" | 50.9
| style="text-align:right" | 49.4
| style="text-align:right" | -2%
|-
| style="text-align:left" | Protection & Health
Line 496 ⟶ 475:
| style="text-align:right" | -4%
|-
| style="text-align:left" | Unit-
| style="text-align:right" | —
| style="text-align:right" | 8.5
Line 511 ⟶ 490:
| style="text-align:right" | -10%
|-
| style="text-align:left
| style="text-align:right" | 2.2
| style="text-align:right" | 2.2
| style="text-align:right" | +3%
|-
| style="text-align:left" | '''NBV (post-tax)'''
| style="text-align:right" | 2.3
| style="text-align:right" | 2.2
| style="text-align:right" | stable
|-
| style="text-align:left" | NBV margin
| style="text-align:right" | 4.4%
| style="text-align:right" | 4.5%
| style="text-align:right" | —
|}
</div>
* '''PVEP''' was impacted by higher interest rates on discounting despite strong growth in Life volumes.
* '''
* '''NBV''' was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France.
=== Life & Health | Growth in new business driving Normalized CSM growth ===
Line 557 ⟶ 514:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | FY24
| style="text-align:right" | 33.6
|-
| style="text-align:left" |
| style="text-align:right" | +2.2
|-
| style="text-align:left" |
| style="text-align:right" | +1.3
|-
Line 573 ⟶ 530:
| style="text-align:right" | -3.0
|-
| style="text-align:left" |
| style="text-align:right" | +0.6
|-
| style="text-align:left" |
| style="text-align:right" | -0.3
|-
| style="text-align:left" |
| style="text-align:right" | -1.4
|-
Line 587 ⟶ 544:
</div>
* '''Normalized CSM'''
* '''Economic variance'''
* '''Operating variance'''
* '''FX impact'''
* FY24: o/w Life: EUR 25.8bn, o/w Health: EUR 7.7bn
* FY25: o/w Life: EUR 25.4bn, o/w Health: EUR 7.6bn
=== Life & Health | Strong momentum in both short-term and long-term business ===
Line 606 ⟶ 562:
| style="text-align:right" | 3,323
|-
| style="text-align:left" |
| style="text-align:right" | +60
|-
| style="text-align:left" |
| style="text-align:right" | +156
|-
| style="text-align:left" |
| style="text-align:right" | -11
|-
| style="text-align:left" |
| style="text-align:right" | -27
|-
Line 623 ⟶ 579:
</div>
* '''Underlying earnings''' +7% LFL to EUR 3,501m.
* '''FY24 components''': Short-term technical margin EUR 415m; Long-term result incl. CSM release EUR 2,680m; Financial result EUR 975m; Tax & others -EUR 748m.
* '''FY25 components''': Short-term technical margin EUR 479m; Long-term result incl. CSM release EUR 2,804m; Financial result EUR 946m; Tax & others -EUR 728m.
* '''Life segment''' underlying earnings EUR 2.7bn (+4% vs. FY24; FY24: EUR 2.6bn).
* '''Health segment''' underlying earnings EUR 0.8bn (+17% vs. FY24; FY24: EUR 0.7bn).
* '''Short-term technical margin''' strong on underwriting and claims initiatives; more than offset legislative change on VAT recoverability in Mexico of -EUR 0.1bn.
* '''Long-term results''' higher from CSM release increase of +8% on reserve base growth, favorable equity markets, and better margins.
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
Line 635 ⟶ 591:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Property & Casualty
Line 659 ⟶ 615:
| style="text-align:right" | -1.2
| style="text-align:right" | -1.2
| style="text-align:right" | flat
|-
| style="text-align:left" | Underlying earnings
| style="text-align:right" | 8.1
| style="text-align:right" | 8.4
| style="text-align:right" | +6%
|-
| style="text-align:left" | Non-financial flows
| style="text-align:right" | -0.5
| style="text-align:right" | 2.1
| style="text-align:right" | —
|-
| style="text-align:left
| style="text-align:right
| style="text-align:right
| style="text-align:right
|-
| style="text-align:left" | Net income
| style="text-align:right" | 7.9
| style="text-align:right" | 9.8
| style="text-align:right" | +26%
|}
</div>
Line 670 ⟶ 641:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Underlying
! style="text-align:left" |
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" |
| style="text-align:right" | +6%
|-
| style="text-align:left" |
| style="text-align:right" | +3%
|-
| style="text-align:left" |
| style="text-align:right" | -2%
|}
</div>
* '''Underlying earnings''' driven by strong performance from insurance businesses.
* '''Holding cost''' stable, expected to remain at current level in 2026.
* '''Net income'''
* '''Financial flows''' lower reflecting unfavorable forex impact.
* '''Capital gains''' from AXA IM disposal: EUR +2.2bn in FY25.
* '''Temporary dilution''' from AXA IM sale: -1% included in forex/capital management, due to the timing of anti-dilutive share buyback.
*
=== Shareholders' Equity ===
* All figures in Euro billion unless otherwise stated <sup>p. 22</sup>.
* (stacked bar) '''Shareholders' equity''' (Group share):
** '''HY25''': EUR 45.5bn total (comprising SHE excl. OCI of EUR 52.7bn and Net OCI of EUR -7.2bn) <sup>p. 22</sup>
** '''FY25''': EUR 47.2bn total (comprising SHE excl. OCI of EUR 54.0bn and Net OCI of EUR -6.8bn) <sup>p. 22</sup>
* '''SHE (excl. OCI & undated subordinated debt)''': EUR 53.2bn in FY24; EUR 47.0bn in HY25; EUR 49.4bn in FY25 <sup>p. 22</sup>
* '''Debt gearing''': 20.6% in FY24; 23.4% in HY25; 22.3% in FY25 <sup>p. 22</sup>
* '''Underlying ROE''': 15.2% in FY24; 17.5% in HY25; 16.0% in FY25 <sup>p. 22</sup>
** '''Opening Shareholders' equity''': EUR 49.9bn (FY24 to FY25); EUR 45.5bn (HY25 to FY25) <sup>p. 22</sup>
** '''Change in Net OCI''': +EUR 1.3bn (FY24 to FY25); +EUR 0.4bn (HY25 to FY25) <sup>p. 22</sup>
** '''Net income for the period''': +EUR 9.8bn (FY24 to FY25); +EUR 5.9bn (HY25 to FY25) <sup>p. 22</sup>
** '''Dividend''': -EUR 4.6bn (FY24 to FY25); nil (HY25 to FY25) <sup>p. 22</sup>
** '''Annual share buyback''': -EUR 1.2bn (FY24 to FY25); nil (HY25 to FY25) <sup>p. 22</sup>
** '''Anti-dilutive share buyback following the sale of AXA IM''': -EUR 3.5bn (FY24 to FY25); -EUR 3.5bn (HY25 to FY25) <sup>p. 22</sup>
** '''Undated subordinated debt (including interest charges)''': -EUR 0.3bn (FY24 to FY25); -EUR 1.2bn (HY25 to FY25) <sup>p. 22</sup>
** '''Forex''': -EUR 3.5bn (FY24 to FY25); -EUR 0.1bn (HY25 to FY25) <sup>p. 22</sup>
** '''Other''': -EUR 0.6bn (FY24 to FY25); +EUR 0.3bn (HY25 to FY25) <sup>p. 22</sup>
** '''Closing Shareholders' equity''': EUR 47.2bn (FY24 to FY25); EUR 47.2bn (HY25 to FY25) <sup>p. 22</sup>
=== Higher organic cash remittance and robust cash position at Holding ===
Line 829 ⟶ 690:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Net
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Net
| style="text-align:right" | 7.7
| style="text-align:right" | 7.5
|-
| style="text-align:left" | Ordinary cash remittance
| style="text-align:right" | 7.1
| style="text-align:right" | 7.5
|-
| style="text-align:left" |
| style="text-align:right" | 0.6
| style="text-align:right" | —
Line 848 ⟶ 709:
</div>
* Remittance ratio was 82% in FY24 and 82% in FY25 <sup>p. 23</sup>
* Proceeds related to in-force treaties of EUR 0.6bn in FY24 related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe <sup>p. 23</sup>
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Holding cash position bridge
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Value
Line 860 ⟶ 721:
| style="text-align:right" | 4.0
|-
| style="text-align:left" | Net cash remittance from subsidiaries
| style="text-align:right" | +7.5
|-
Line 869 ⟶ 730:
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Holding costs and interest expenses
| style="text-align:right" | -1.3
|-
Line 885 ⟶ 746:
|}
</div>
=== Solvency II at 224% ===
Line 895 ⟶ 753:
|+ Solvency II walk, FY24 to FY25 <sup>p. 24</sup>
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | Solvency
|-
| style="text-align:left" | FY24
| style="text-align:right" | 216
| style="text-align:right" | 55.9
| style="text-align:right" | 25.9
|-
| style="text-align:left" | Regulatory & model changes
| style="text-align:right" | +0
| style="text-align:right" | +0.2
| style="text-align:right" | 0.0
|-
| style="text-align:left" | Normalized capital generation
| style="text-align:right" | +28
| style="text-align:right" | +8.8
| style="text-align:right" | +0.6
|-
| style="text-align:left" | Operating variance
| style="text-align:right" | -1
| style="text-align:right" | -0.4
| style="text-align:right" | 0.0
|-
| style="text-align:left" | Economic variance & FX
| style="text-align:right" | +4
| style="text-align:right" | -2.1
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Dividend & annual share buyback
| style="text-align:right" | -24
| style="text-align:right" | -6.0
| style="text-align:right" | 0.0
|-
| style="text-align:left" | Management actions, debt & other
| style="text-align:right" | +2
| style="text-align:right" | -0.1
| style="text-align:right" | -0.2
|-
| style="text-align:left" | FY25
| style="text-align:right" | 224
| style="text-align:right" | 56.4
| style="text-align:right" | 25.2
|}
</div>
* Dividend & annual share buyback
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Solvency II sensitivities (impact on 224% base ratio as of December 31, 2025) <sup>p. 24</sup>
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Impact (pts)
Line 965 ⟶ 822:
| style="text-align:right" | -4
|-
| style="text-align:left" | Listed Equity
| style="text-align:right" | -1
|-
| style="text-align:left" | Listed Equity
| style="text-align:right" | +2
|-
Line 982 ⟶ 839:
</div>
* Euro Sovereign spreads +50bps assumes 50bps spread widening of Euro sovereign bonds vs. Euro swap curve applied on sovereign and quasi-sovereign exposures <sup>p. 24</sup>
* Credit migration assumes 20% of corporate bonds, including private debt, held are downgraded by one full letter / 3 notches <sup>p. 24</sup>
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Solvency II ratio evolution <sup>p. 25</sup>
! style="text-align:left" | Solvency II ratio
! class="col-s" style="text-align:right" | Value
|-
| style="text-align:left" | As of December 31, 2025
| style="text-align:right" | 224%
|-
| style="text-align:left" | Grandfathering end impact on January 1, 2026
| style="text-align:right" | -10pts
|-
| style="text-align:left" | Ratio after grandfathering impact
| style="text-align:right" | 215%
|-
| style="text-align:left" | Solvency II revision impact (estimated)
| style="text-align:right" | +17pts
|}
</div>
* EUR 2.4bn grandfathered debt is no longer eligible as capital from January 1, 2026.
* No change is expected in organic capital generation.
* Provides additional capital flexibility.
* ¹ Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.
* '''Solvency II revision''' impact to come into effect in 1Q27 is estimated at +17pts¹ <sup>p. 25</sup>.
=== Thomas Buberl, Group CEO conclusion ===
* '''
=== Conclusion ===
* '''Record results''' achieved at the top end of the target range while enhancing reserve prudence <sup>p. 27</sup>.
* '''
* '''Diversified franchise''' is well-positioned to capture future growth opportunities <sup>p. 27</sup>.
* '''
=== February 26, 2026 Q&A Full Year 2025 earnings ===
* '''
=== AXA Investor Relations | Keep in touch ===
* '''Investor Relations contact''': +33 1 40 75 48 42; investor.relations@axa.com <sup>p. 29</sup>
* '''Financial calendar''':
**
**
**
**
** '''
** '''
== Appendices ==
*
* '''Debt and Invested Assets''' <sup>p. 31</sup>
* '''Additional P&C disclosures''' <sup>p. 36</sup>
* '''Sustainability''' <sup>p. 44</sup>
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
* '''Debt gearing''' was 20.6% in FY24 and 22.3% in FY25 <sup>p. 32</sup>.
* (stacked bar) '''Gross financial debt''' (nominal debt basis):
** '''
** '''
** '''Jan 1st 2026''' (End of the grandfathering period): EUR 20.3bn total (Tier 1: EUR 3.2bn, Tier 2: EUR 11.3bn, Senior debt: EUR 5.8bn; of which EUR 0.4bn redeemed in Jan 2026) <sup>p. 32</sup>
* (stacked bar) '''Contractual maturity breakdown''' (EUR billion):
** '''2028''': EUR 0.5bn (Senior debt) <sup>p. 32</sup>
** '''2030''': EUR 0.9bn total (Tier 2: EUR 0.7bn, Senior debt: EUR 0.2bn) <sup>p. 32</sup>
Line 1,058 ⟶ 919:
** '''≥2040''': EUR 11.3bn total (Tier 2: EUR 10.8bn, Senior debt: EUR 0.5bn) <sup>p. 32</sup>
** '''Undated''': EUR 5.3bn total (Tier 1: EUR 4.6bn, Tier 2: EUR 0.7bn) <sup>p. 32</sup>
** '''Of which
* (
** '''2026''': EUR 0.1bn (Tier 1) <sup>p. 32</sup>
** '''2027''': EUR 2.4bn (Tier 2) <sup>p. 32</sup>
Line 1,065 ⟶ 926:
** '''2029''': EUR 2.0bn (Tier 2) <sup>p. 32</sup>
** '''2030''': EUR 0.9bn total (Tier 2: EUR 0.7bn, Senior debt: EUR 0.2bn) <sup>p. 32</sup>
** '''2031-2039''': EUR 1.
** '''≥2040''': EUR 0.5bn (Senior debt) <sup>p. 32</sup>
** '''Undated''': EUR 4.7bn total (Tier 1: EUR 4.0bn, Tier 2: EUR 0.7bn) <sup>p. 32</sup>
** '''Of which
*
=== General Account invested assets ===
Line 1,076 ⟶ 936:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | Value
Line 1,085 ⟶ 945:
| style="text-align:right" | 77%
|-
| style="text-align:left; padding-left:1.5em" | o/w Government bonds
| style="text-align:right" | 167
| style="text-align:right" | 37%
|-
| style="text-align:left; padding-left:1.5em" | o/w Corporate bonds and loans
| style="text-align:right" | 121
| style="text-align:right" | 27%
|-
| style="text-align:left; padding-left:1.5em" | o/w Other fixed income
| style="text-align:right" | 56
| style="text-align:right" | 13%
Line 1,127 ⟶ 987:
</div>
* Total General Account invested assets: EUR 450bn
* Other fixed income includes Asset Backed Securities
* Listed equities includes hedges;
* Private equity and hedge funds includes Private Equity
=== Structured and Private Credit assets ===
Line 1,136 ⟶ 996:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Structured assets and
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" | Value
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | Residential
| style="text-align:right" | 16
| style="text-align:right" | 4%
Line 1,157 ⟶ 1,017:
| style="text-align:right" | 2%
|-
| style="text-align:left" | Mid-
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | Other assets
| style="text-align:right" | 2
| style="text-align:right" | 0%
|-
| style="text-align:left; font-weight:bold" | Total
| style="text-align:right; font-weight:bold" | 69
| style="text-align:right; font-weight:bold" | 15%
Line 1,171 ⟶ 1,031:
</div>
* Residential
* Residential mortgages includes EUR 10bn self-originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
* CLO & ABS: 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
* Infrastructure debt: skewed towards resilient industries
* CRE debt: strong sector diversification (mainly logistics, residential, and retail), mostly in Europe, and circa 60% LTV
* Mid-
* Mid-market lending: investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales, and sector allocation
* Total structured assets and private credit assets: 54% is participating
=== Investment portfolio | Fixed Income reinvestment ===
Line 1,182 ⟶ 1,044:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion unless otherwise mentioned
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" | Reinvestment yield
|-
| style="text-align:left" | Government bonds & related
| style="text-align:right" | 32%
| style="text-align:right" | AA
| style="text-align:right" | —
|-
| style="text-align:left" | Investment grade credit
| style="text-align:right" | 40%
| style="text-align:right" |
| style="text-align:right" | —
|-
| style="text-align:left" | ABS/CLO/IG fund financing
| style="text-align:right" | 21%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Below investment grade credit
| style="text-align:right" | 7%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Public fixed income
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 3.5%
|-
| style="text-align:left" | Private & Structured fixed income
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | 4.7%
|-
| style="text-align:left; font-weight:bold" | Total fixed income
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | —
| style="text-align:right; font-weight:bold" | 3.9%
Line 1,217 ⟶ 1,087:
</div>
* Fixed income reinvestment totaled EUR 57bn in FY25.
* Reinvestment duration averaged 9 years.
* Private & Structured credit reinvestment was EUR 19.7bn at 4.7% yield, covering CLOs, ABS, Infra & CRE debt, Fund financing, and Private HY.
* Strategic asset shift from alternative total return assets to Private & Structured credit.
* '''
**
** 2. '''Additional P&C disclosures''' <sup>p. 36</sup>
** 3. Additional IFRS17 disclosures <sup>p. 41</sup>
** 4. Sustainability <sup>p. 44</sup>
=== AXA XL Insurance | Large Commercial & Specialty business ===
Line 1,230 ⟶ 1,102:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ FY25 GWP
! style="text-align:left" | USD billion unless otherwise mentioned
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | '''GWP by line of business'''
| style="text-align:right" | —
|-
| style="text-align:left" | Casualty
| style="text-align:right" | 35%
|-
| style="text-align:left" | Property
| style="text-align:right" | 29%
|-
| style="text-align:left" | Specialty
| style="text-align:right" | 19%
|-
| style="text-align:left" | Professional lines (including Cyber)
| style="text-align:right" | 17%
|-
| style="text-align:left" | '''GWP by geography'''
| style="text-align:right" | —
|-
| style="text-align:left" | Americas
| style="text-align:right" | 46%
|-
| style="text-align:left" | Europe & APAC
| style="text-align:right" | 35%
|-
| style="text-align:left" | UK & Lloyds
| style="text-align:right" | 19%
|}
</div>
* AXA XL Insurance is well diversified across lines of business and geographies, with USD 19bn FY25 GWP.
* Market leadership positions AXA XL as top 3 globally in:
** Multinational Programs
** Marine
** Fine Art & Specie
* (bubble chart) '''Managing the cycle''' to deliver consistent profitability (Profitability vs Ex-price growth %):
** '''Property''': Highest profitability and highest ex-price growth
** '''Specialty''': Medium-high profitability and medium-high ex-price growth
** '''Casualty''': Medium-low profitability and medium-low ex-price growth
** '''Professional lines''': Lowest profitability and lowest ex-price growth
=== P&C | Focus on Reserves ===
Line 1,272 ⟶ 1,149:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Claims and
! style="text-align:left" | %
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" |
| style="text-align:right" | 179
| style="text-align:right" | —
| style="text-align:right" | 213
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | 185
| style="text-align:right" | —
| style="text-align:right" | 227
| style="text-align:right" | —
|-
| style="text-align:left" | FY20
| style="text-align:right" | 193
| style="text-align:right" | —
| style="text-align:right" | 233
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | —
| style="text-align:right" | 226
| style="text-align:right" | —
|-
| style="text-align:left" | FY22
| style="text-align:right" | 189
| style="text-align:right" | 198
| style="text-align:right" | 227
| style="text-align:right" | 234
|-
| style="text-align:left" | FY23
| style="text-align:right" | —
| style="text-align:right" | 195
| style="text-align:right" | —
| style="text-align:right" | 232
|-
| style="text-align:left" |
| style="text-align:right" | —
| style="text-align:right" | 180
| style="text-align:right" | —
| style="text-align:right" | 216
|-
| style="text-align:left" | FY25
| style="text-align:right" | —
| style="text-align:right" | 175
| style="text-align:right" | —
| style="text-align:right" |
|}
</div>
* Technical reserves include net undiscounted claims reserves and unearned premium reserves.
=== P&C | 2026 Simplified Group Nat Cat Reinsurance Program 1 ===
Line 1,329 ⟶ 1,211:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" | EUR billion
! class="col-s" style="text-align:right" | Capacity
Line 1,354 ⟶ 1,236:
| style="text-align:right" | 600m
|-
| style="text-align:left" |
| style="text-align:right" | —
| style="text-align:right" | 400m
Line 1,360 ⟶ 1,242:
</div>
* '''Retention levels
* (diagram) '''Reinsurance segment''' (illustrative) utilizes Alternative Capital & Cat Bonds <sup>p. 39</sup>.
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
* '''Earnings deviation''' to average Nat Cat charges in 2026 (net of reinsurance, post-tax) shows negative deviation in ca. 40% of cases (more severe years) and positive deviation in ca. 60% of cases (less severe years) <sup>p. 40</sup>.
* (bar chart) '''Group underlying earnings''' deviation to average Nat Cat charges in 2026:
** '''1/20y (95th percentile)''': EUR -1.2bn <sup>p. 40</sup>
** '''
** '''
** '''Median (50th percentile)''': EUR +0.1bn <sup>p. 40</sup>
*
** '''
** '''
* (bar chart) '''Average expected Nat Cat''' charges (net of reinsurance, pre-tax):
** '''2025''': 2.6, with estimated impact on GEP of ca. 4.5% <sup>p. 40</sup>
** '''2026''': 2.7, with estimated impact on GEP of ca. 4.5% <sup>p. 40</sup>
* '''Natural catastrophe cost''' is defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance <sup>p. 40</sup>.
* '''Deviation comparison''' is made to a normalized level, which represents costs associated with natural catastrophes expected in an average year, at ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance <sup>p. 40</sup>.
* '''Table of contents''' section divider <sup>p. 41</sup>:
** 1. Debt and Invested Assets <sup>p. 31</sup>
** 2. Additional P&C disclosures <sup>p. 36</sup>
Line 1,388 ⟶ 1,272:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ P&C margin analysis, FY25 vs FY24
! style="text-align:left" | EUR million unless otherwise mentioned
! class="col-s" style="text-align:right" | FY25
Line 1,394 ⟶ 1,278:
! class="col-m" style="text-align:right" | Other metrics
|-
| style="text-align:left" |
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Undiscounted technical margin (current accident year)
| style="text-align:right" | 2,778
| style="text-align:right" | +707
| style="text-align:right" | —
|-
| style="text-align:left" | Gross
| style="text-align:right" | 57,656
| style="text-align:right" | +6%
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | 95.2%
| style="text-align:right" | -1.0pt
Line 1,414 ⟶ 1,303:
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | 2,009
| style="text-align:right" | +115
| style="text-align:right" | —
|-
| style="text-align:left" | Discounting
| style="text-align:right" | -3.5%
| style="text-align:right" | +0.0pt
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | 19.0bn
| style="text-align:right" | —
Line 1,434 ⟶ 1,323:
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | 2.8%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Prior
| style="text-align:right" | 622
| style="text-align:right" | -341
Line 1,449 ⟶ 1,338:
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | —
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Investment income
| style="text-align:right" | 3,988
| style="text-align:right" | +435
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | 115bn
| style="text-align:right" | —
Line 1,464 ⟶ 1,358:
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | 4.3%
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | Insurance
| style="text-align:right" | -1,358
| style="text-align:right" | -235
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | 71bn
| style="text-align:right" | —
Line 1,484 ⟶ 1,378:
| style="text-align:right" | —
|-
| style="text-align:left" | '''Underlying
| style="text-align:right" | 8,040
| style="text-align:right" | +681
Line 1,494 ⟶ 1,388:
| style="text-align:right" | —
|-
| style="text-align:left" | Affiliates,
| style="text-align:right" | -108
| style="text-align:right" | -10
| style="text-align:right" | —
|-
| style="text-align:left" | '''Underlying
| style="text-align:right" | 5,872
| style="text-align:right" | +501
| style="text-align:right" | +9% growth vs
|}
</div>
Line 1,508 ⟶ 1,402:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+
! style="text-align:left" |
! class="col-s" style="text-align:right" |
|-
| style="text-align:left" | +25bps
Line 1,522 ⟶ 1,416:
<div style="overflow-x:auto">
{| class="wikitable"
|+
! style="text-align:left" | Item
! class="col-s" style="text-align:right" | Value
|-
| style="text-align:left" | 2026e
| class="col-s" style="text-align:right" | ~ -1.4bn
|}
</div>
<div style="overflow-x:auto">
{| class="wikitable"
|+ Sensitivity of 2026e expenses to changes in 2025 current accident year discount <sup>p. 42</sup>
! style="text-align:left" | Shift
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" |
| class="col-s" style="text-align:right" | ~ -50m
|-
| style="text-align:left" |
| class="col-s" style="text-align:right" | ~ +50m
|}
Line 1,541 ⟶ 1,443:
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ L&H margin analysis, FY25 vs FY24
! style="text-align:left" | EUR million unless otherwise mentioned
! class="col-
! class="col-s" style="text-align:right" | Change vs FY24
! class="col-m" style="text-align:right" | Other metrics
|-
| style="text-align:left" | '''Short-term Technical Margin'''
| style="text-align:right" | 479
| style="text-align:right" | +60
| style="text-align:right" |
|-
| style="text-align:left" | Gross
| style="text-align:right" | 17,416
| style="text-align:right" | +10%
| style="text-align:right" | —
|-
| style="text-align:left" | All
| style="text-align:right" | 97.2%
| style="text-align:right" | -0.
| style="text-align:right" |
|-
| style="text-align:left" | '''Long-term Technical Margin'''
| style="text-align:right" | 2,804
| style="text-align:right" | +156
Line 1,577 ⟶ 1,479:
| style="text-align:right" | —
|-
| style="text-align:left" | '''Investment Income (non-VFA only)'''
| style="text-align:right" | 2,484
| style="text-align:right" | -1
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | 98bn
| style="text-align:right" | —
Line 1,592 ⟶ 1,494:
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | 3.8% on fixed income assets
| style="text-align:right" | —
| style="text-align:right" | —
|-
| style="text-align:left" | '''Insurance Finance Expenses (non-VFA only)'''
| style="text-align:right" | -1,538
| style="text-align:right" | -9
| style="text-align:right" | —
|-
| style="text-align:left" |
| style="text-align:right" | 62bn (FY24)
| style="text-align:right" | —
| style="text-align:right" | —
Line 1,612 ⟶ 1,514:
| style="text-align:right" | —
|-
| style="text-align:left" | '''Underlying Earnings before tax'''
| style="text-align:right" | 4,229
| style="text-align:right" | +205
Line 1,622 ⟶ 1,524:
| style="text-align:right" | —
|-
| style="text-align:left" | Affiliates,
| style="text-align:right" | 72
| style="text-align:right" | -51
| style="text-align:right" | —
|-
| style="text-align:left" | '''Underlying Earnings'''
| style="text-align:right" | 3,501
| style="text-align:right" | +219
| style="text-align:right" | +7% growth vs
|}
</div>
Line 1,637 ⟶ 1,539:
{| class="wikitable fintable"
|+ Life & Health FY25 CSM Key Sensitivities <sup>p. 43</sup>
! style="text-align:left" |
! class="col-s" style="text-align:right" | EUR billion
|-
Line 1,668 ⟶ 1,570:
|}
</div>
* '''L&H margin analysis''' includes scope impact <sup>p. 43</sup>.
* '''Table of contents'''
** 1. '''Debt and Invested Assets''' <sup>p. 31</sup>
** 2. '''Additional P&C disclosures''' <sup>p. 36</sup>
** 3. '''Additional IFRS17 disclosures''' <sup>p. 41</sup>
** 4. '''Sustainability''' <sup>p. 44</sup>
Line 1,679 ⟶ 1,582:
<div style="overflow-x:auto">
{| class="wikitable"
|+
! style="text-align:left" |
! class="col-m" style="text-align:right" | Metric
! class="col-m" style="text-align:right" | Target
! class="col-m" style="text-align:right" | 2025 Result
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" | Climate transition financing
| class="col-m" style="text-align:right" | EUR 5bn per year
| class="col-m" style="text-align:right" | EUR 6.4bn
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" | Community resilience financing
| class="col-m" style="text-align:right" | >EUR 500m per year
| class="col-m" style="text-align:right" | EUR 1.4bn
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" | EUR 6bn in P&C GWP (cumulative 2024-2026)
| class="col-m" style="text-align:right" | EUR 4.6bn
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" | 19,698 (cumulative 2024-2025)
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" | >20m customers by 2026
| class="col-m" style="text-align:right" | 20.6m
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" |
| class="col-m" style="text-align:right" | >80,000 AXA Group employees trained on climate adaptation by 2026
| class="col-m" style="text-align:right" | 46,420
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" | Net-
| class="col-m" style="text-align:right" | -50% by 2030 in absolute carbon emissions and offset of residual emissions
| class="col-m" style="text-align:right" | -64% reduction against 2019
|-
| style="text-align:left" |
| class="col-m" style="text-align:right" | Employee volunteering
| class="col-m" style="text-align:right" | 50% of AXA Group employees engaged in volunteering activities by 2026
| class="col-m" style="text-align:right" | 56%
|}
</div>
=== Sustainability Performance & Ratings ===
Line 1,725 ⟶ 1,635:
{| class="wikitable"
|+ ESG ratings and scores <sup>p. 46</sup>
! style="text-align:left" |
! class="col-m" style="text-align:right" | 2025 Score /
|-
| style="text-align:left" | S&P Global
| class="col-m" style="text-align:right" | 97th percentile
|-
| style="text-align:left" | MSCI
Line 1,741 ⟶ 1,651:
|-
| style="text-align:left" | FTSE Russell
| class="col-m" style="text-align:right" | 4.3/5
|}
</div>
*
* '''S&P Global''' 2025 percentile was 97th (footnote 1) in Dow Jones Best-in-Class Europe & World indices <sup>p. 46</sup>.
* '''FTSE Russell''' 2025 score was 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup>.
=== Scope ===
* '''France'''
* '''Europe'''
* '''AXA XL'''
* '''Asia, Africa & EME-LATAM'''
** '''Asia''': Japan (insurance
** '''Africa''': Morocco (insurance
** '''EME-LATAM''': Mexico (insurance
** '''AXA Mediterranean Holdings''' <sup>p. 47</sup>.
* '''Transversal & Other'''
* '''AXA Investment Managers''' (until July 1, 2025)
* '''Accounting standards''' note:
=== Glossary ===
* '''Capital-light G/A products''': encompass all products with no guarantees, with guarantees at maturity only or with guarantees equal to or lower than 0% <sup>p. 48</sup>
* '''Contractual Service Margin
* '''CSM release''': a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss representing the estimated profit earned by the insurer for providing insurance services during the reporting period <sup>p. 48</sup>
* '''Economic variance''': corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force <sup>p. 48</sup>
* '''Financial result''': consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow <sup>p. 48</sup>
* '''Gross Written Premiums
* '''New Business Value
* '''New Business
* '''New Business Value margin
* '''Operating variance''': the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes
* '''Present value of expected premiums
* '''Technical experience''': consists of the impacts on the underlying earnings of (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses <sup>p. 48</sup>
* '''Underlying return on in-force''': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>
Line 1,778 ⟶ 1,690:
=== February 26, 2026 Thank you Full Year 2025 earnings ===
* '''
== Abbreviations ==
* '''AA''': Senior
* '''AAA''': Senior
* '''ABS''': Asset-Backed Securities
* '''AEP''': Aggregate Exceedance Probability
Line 1,789 ⟶ 1,701:
* '''APAC''': Asia-Pacific
* '''AXA IM''': AXA Investment Managers
* '''BBA''': Benefits-Based Annuities
* '''CDP''': Carbon Disclosure Project
* '''CLO''': Collateralized Loan Obligation
Line 1,797 ⟶ 1,707:
* '''CSA''': Corporate Sustainability Assessment
* '''CSM''': Contractual Service Margin
* '''CY''':
* '''DPS''': Dividend Per Share
* '''EME''':
* '''EOF''': Eligible Own Funds
* '''EPS''': Earnings Per Share
* '''ESG''': Environmental, Social, and Governance
* '''EU''': European Union
* '''FX''': Foreign Exchange
* '''GAAP''': Generally Accepted Accounting Principles
* '''GEP''': Gross Earned Premiums
* '''GWP''': Gross Written Premiums
* '''HKD''': Hong Kong Dollar
Line 1,821 ⟶ 1,728:
* '''LTV''': Loan-to-Value
* '''MSCI''': Morgan Stanley Capital International
* '''NA''': North America
* '''NB CSM''': New Business Contractual Service Margin
* '''NBV''': New Business Value
* '''NHG''': Nationale Hypotheek Garantie
* '''NPS''': Net Promoter Score
* '''OCI''': Other Comprehensive Income
Line 1,832 ⟶ 1,738:
* '''PVEP''': Present Value of Expected Profits
* '''PYD''': Prior Years' Reserve Development
* '''
* '''ROE''': Return on Equity
* '''SCR''': Solvency Capital Requirement
* '''SHE''': Shareholders' Equity
* '''SME''': Small and Medium-sized Enterprises
* '''TVOG''': Time Value of Options
* '''UEPS''': Underlying Earnings Per Share
* '''UK''': United Kingdom
| |||